Exploratory solid-phase synthesis of factor Xa inhibitors:: Discovery and application of P3-heterocyclic amides as novel types of non-basic arginine surrogates

被引:7
作者
Ho, JZ [1 ]
Levy, OE [1 ]
Gibson, TS [1 ]
Nguyen, K [1 ]
Semple, JE [1 ]
机构
[1] Corvas Int Inc, Dept Med Chem, San Diego, CA 92121 USA
关键词
D O I
10.1016/S0960-894X(99)00628-9
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel FXa inhibitors 2a-m and 3a-f was discovered that feature heterocyclic carboxamides tethered to a d-diaminobutyric acid sidechain. These neutral amide derivatives serve as novel P-3 d-arginine mimics. Pyrazine carboxamide scaffolds afforded the most potent FXa inhibitors (e.g., 2b IC50 = 4.6 nM). The synthesis and biological activity of two focused libraries are reported. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3459 / 3464
页数:6
相关论文
共 16 条
[1]  
ABELMAN MM, 1996, Patent No. 19493
[2]   Highly selective mechanism-based thrombin inhibitors: Structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes [J].
Krishnan, R ;
Zhang, E ;
Hakansson, K ;
Arni, RK ;
Tulinsky, A ;
Lim-Wilby, MSL ;
Levy, OE ;
Semple, JE ;
Brunck, TK .
BIOCHEMISTRY, 1998, 37 (35) :12094-12103
[3]  
Marlowe C. K., 1998, Patent, Patent No. [US005721214A, 005721214]
[5]   Alkoxide-catalyzed ring-opening of a novel homosaccharin derivative:: Synthesis of potent, selective P3-lactam thrombin inhibitors containing P4-o-alkoxycarbonylbenzylsulfonamide residues' [J].
Owens, TD ;
Semple, JE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (24) :3683-3688
[6]   Investigation of the S3 site of thrombin:: Design, synthesis and biological activity of 4-substituted 3-amino-2-pyridones incorporating P1-argininals [J].
Reiner, JE ;
Lim-Wilby, MS ;
Brunck, TK ;
Ha-Uong, T ;
Goldman, EA ;
Abelman, MA ;
Nutt, RF ;
Semple, JE ;
Tamura, SY .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (06) :895-900
[7]   Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin:: Implications for the inhibition of factor Xa, tPA, and urokinase [J].
Renatus, M ;
Bode, W ;
Huber, R ;
Stürzebecher, J ;
Stubbs, MT .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (27) :5445-5456
[8]   Antithrombotics serine proteases [J].
Ripka, WC ;
Vlasuk, GP .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 32, 1997, 32 :71-89
[9]   New thrombin inhibitors in cardiovascular disease [J].
Ripka, WC .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (02) :242-253
[10]  
RIPKA WC, 1997, STRUCTURE BASED DRUG, pCH11